Medicare for America Act of 2019
Latest action · Dec 21, 2022 Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, the Judiciary, Natural Resources, Education and Labor, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedDec 21, 2022
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Medicare for America Act of 2019 [sic]
This bill establishes several health insurance programs and otherwise modifies certain requirements relating to health care coverage, costs, and services.
In particular, the bill establishes a national health insurance program to be administered by the Department of Health and Human Services (HHS). Among other requirements, the program must (1) cover all U.S. residents; (2) cover specified items and services, including hospital services, prescription drugs, dental services, and home- and community-based long-term care; and (3) be fully implemented in 2026. HHS must also offer a transitional public health option that provides certain minimum coverage through health insurance exchanges in 2024 and 2025.
The bill also makes a series of other changes to health care and tax provisions. For example, the bill (1) allows federal funds to be used for abortions; (2) sunsets a specified tax reform law that, among other things, repealed the penalty for failing to maintain minimum essential health coverage; and (3) prohibits excessive prices for prescription drugs and medical devices, as determined by a newly established federal regulatory board.
Cosponsors 5
Members who signed on, in the order they did. Signatures ran from Dec 21, 2022 to Dec 22, 2022, with 4 there on the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-IL | Janice D. Schakowsky | Original | Dec 21, 2022 |
| D-TX | Lloyd Doggett | Original | Dec 21, 2022 |
| D-AZ | Raúl M. Grijalva | Original | Dec 21, 2022 |
| D-CA | Zoe Lofgren | Original | Dec 21, 2022 |
| D-PA | Mary Gay Scanlon | Dec 22, 2022 |
Actions 2
Everything that happened, newest first.
- Dec 21, 2022Introduced in House
- Dec 21, 2022Referred to the Committee on Ways and Means, and in addition to the Committees on Energy and Commerce, the Judiciary, Natural Resources, Education and Labor, and House Administration, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 898 | Fair Accountability and Innovative Research Drug Pricing Act of 2021 | Related bill | Mar 23, 2021 |
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Dec 21, 2022Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.